Investigating the potential role of BDNF and PRL genotypes on antidepressant response in depression patients: A prospective inception cohort study in treatment-free patients; Journal of Affective Disorders; Vol. 259
| Parent link: | Journal of Affective Disorders Vol. 259.— 2019.— [P. 432-439] |
|---|---|
| Institution som forfatter: | |
| Andre forfattere: | , , , , , , , , , , , |
| Summary: | Title screen Background:Brain-derived neurotrophic factor (BDNF) is associated with response to antidepressant drugs inmood and anxiety disorders. Prolactin (PRL) is a pituitary hormone with behavioural effects, acting as a neu-rotrophic factor within the brain and may be involved in antidepressant response.Objectives:To investigate the relationship betweenBDNFandPRLgenotypes with antidepressant drug response.Methods:Prospective inception cohort of 186 Russian treatment-free participants (28 men and 158 women)between 18 and 70 years clinically diagnosed with depressive disorder who initiated antidepressant medication.DNA polymorphisms were genotyped forPRLrs1341239,BDNFrs6265 and rs7124442. Primary outcome wasmeasured by differences in Hamilton Depression Rating Scale (ΔHAM-D) scores between baseline/week two,week two/week four, and baseline/week four. Linear regression and independentt-test determined the sig-nificance between polymorphisms andΔHAM-D. Results: Comparisons between genotypes did not reveal any significant differences in scores during thefirst twoweeks of treatment. In the latter two weeks, BDNFrs7124442 homozygous C patients responded significantlyworse in comparison to homozygous T patients during this period. Further analysis within women and in post-menopausal women found a similar comparison between alleles. Limitations: Study lasted four weeks, which may be considered short to associate genuine antidepressant effects.Conclusions:Patients taking tricylic antidepressants were noted to have a significant improvement inΔHAM-Dcompared to patients taking SSRIs. Homozygous CBDNFrs712442 patients were found to respond significantlyworse in the last two weeks of treatment. Режим доступа: по договору с организацией-держателем ресурса |
| Sprog: | engelsk |
| Udgivet: |
2019
|
| Fag: | |
| Online adgang: | https://doi.org/10.1016/j.jad.2019.08.058 |
| Format: | MixedMaterials Electronisk Book Chapter |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=661164 |
MARC
| LEADER | 00000naa0a2200000 4500 | ||
|---|---|---|---|
| 001 | 661164 | ||
| 005 | 20250411143558.0 | ||
| 035 | |a (RuTPU)RU\TPU\network\31411 | ||
| 035 | |a RU\TPU\network\31217 | ||
| 090 | |a 661164 | ||
| 100 | |a 20191121d2019 k||y0rusy50 ba | ||
| 101 | 0 | |a eng | |
| 135 | |a drcn ---uucaa | ||
| 181 | 0 | |a i | |
| 182 | 0 | |a b | |
| 200 | 1 | |a Investigating the potential role of BDNF and PRL genotypes on antidepressant response in depression patients: A prospective inception cohort study in treatment-free patients |f T. Ochi [et al.] | |
| 203 | |a Text |c electronic | ||
| 300 | |a Title screen | ||
| 330 | |a Background:Brain-derived neurotrophic factor (BDNF) is associated with response to antidepressant drugs inmood and anxiety disorders. Prolactin (PRL) is a pituitary hormone with behavioural effects, acting as a neu-rotrophic factor within the brain and may be involved in antidepressant response.Objectives:To investigate the relationship betweenBDNFandPRLgenotypes with antidepressant drug response.Methods:Prospective inception cohort of 186 Russian treatment-free participants (28 men and 158 women)between 18 and 70 years clinically diagnosed with depressive disorder who initiated antidepressant medication.DNA polymorphisms were genotyped forPRLrs1341239,BDNFrs6265 and rs7124442. Primary outcome wasmeasured by differences in Hamilton Depression Rating Scale (ΔHAM-D) scores between baseline/week two,week two/week four, and baseline/week four. Linear regression and independentt-test determined the sig-nificance between polymorphisms andΔHAM-D. | ||
| 330 | |a Results: Comparisons between genotypes did not reveal any significant differences in scores during thefirst twoweeks of treatment. In the latter two weeks, BDNFrs7124442 homozygous C patients responded significantlyworse in comparison to homozygous T patients during this period. Further analysis within women and in post-menopausal women found a similar comparison between alleles. Limitations: Study lasted four weeks, which may be considered short to associate genuine antidepressant effects.Conclusions:Patients taking tricylic antidepressants were noted to have a significant improvement inΔHAM-Dcompared to patients taking SSRIs. Homozygous CBDNFrs712442 patients were found to respond significantlyworse in the last two weeks of treatment. | ||
| 333 | |a Режим доступа: по договору с организацией-держателем ресурса | ||
| 461 | |t Journal of Affective Disorders | ||
| 463 | |t Vol. 259 |v [P. 432-439] |d 2019 | ||
| 610 | 1 | |a электронный ресурс | |
| 610 | 1 | |a труды учёных ТПУ | |
| 610 | 1 | |a major depressive disorder | |
| 610 | 1 | |a prolactin | |
| 610 | 1 | |a brain derived neurotrophic factor | |
| 610 | 1 | |a rs6265rs7124442 | |
| 610 | 1 | |a antidepressant response | |
| 610 | 1 | |a депрессивные расстройства | |
| 610 | 1 | |a антидепрессанты | |
| 701 | 1 | |a Ochi |b T. | |
| 701 | 1 | |a Vyalova |b N. N. |g Nataljya Mikhaylovna | |
| 701 | 1 | |a Losenkov |b I. S. |g Innokenty Sergeevich | |
| 701 | 1 | |a Levchuk |b L. A. |g Lyudmila Aleksandrovna | |
| 701 | 1 | |a Osmanova |b D. Z. |g Diana Zakirovna | |
| 701 | 1 | |a Mikhalitskaya |b E. V. | |
| 701 | 1 | |a Loonen |b A. J. M. |g Anton | |
| 701 | 1 | |a Bosker |b F. J. |g Fokko | |
| 701 | 1 | |a Simutkin |b G. G. |g German Gennadjevich | |
| 701 | 1 | |a Bokhan |b N. | |
| 701 | 1 | |a Wilffert |b B. |g Bob | |
| 701 | 1 | |a Ivanova |b S. A. |c specialist in the field of ecology and life safety |c Professor of Tomsk Polytechnic University, doctor of medical sciences |f 1964- |g Svetlana Aleksandrovna |3 (RuTPU)RU\TPU\pers\33859 | |
| 712 | 0 | 2 | |a Национальный исследовательский Томский политехнический университет |b Инженерная школа неразрушающего контроля и безопасности |b Отделение контроля и диагностики |3 (RuTPU)RU\TPU\col\23584 |
| 801 | 2 | |a RU |b 63413507 |c 20191121 |g RCR | |
| 856 | 4 | |u https://doi.org/10.1016/j.jad.2019.08.058 | |
| 942 | |c CF | ||